Pharmacodynamic-Guided Dose Finding Study of Rapamycin (Rapamune®, Sirolimus) in Adult Patients With Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 06 Aug 2010
At a glance
- Drugs Sirolimus (Primary)
- Indications Cancer; Solid tumours
- Focus Adverse reactions
- 06 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Aug 2010 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
- 18 Oct 2006 New trial record.